Header Logo

Connection

CHARLES WYKOFF to Neurofibromin 2

Back to Details
This is a "connection" page, showing publications CHARLES WYKOFF has written about Neurofibromin 2.
CHARLES WYKOFF
Connection Strength
0.051
Neurofibromin 2
  1. MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid. Ophthalmology. 2022 09; 129(9):974-985.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.